ヘルスケア株
| # | 過去7日 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3442 |  SPOK Spok Holdings, Inc. - Common Stock | 10.61 USD | -1.12% | -1.85% | +2.81% | -33.10% | 221.94 M USD | ||
| 3444 |  MOVE Corvex, Inc. - Common Stock | 8.01 USD | -4.76% | -16.48% | -21.85% | +7.37% | 221.45 M USD | ||
| 3449 |  PROF Profound Medical Corp. - common stock | 6.01 USD | -4.75% | -13.28% | +2.74% | +9.87% | 219.56 M USD | ||
| 3455 |  LXEO Lexeo Therapeutics, Inc. - Common Stock | 2.64 USD | -4.35% | -18.01% | -36.54% | -72.73% | 216.60 M USD | ||
| 3465 |  FATE Fate Therapeutics, Inc. - Common Stock | 1.79 USD | -7.25% | -15.96% | -30.08% | +19.33% | 214.48 M USD | ||
| 3470 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 14.55 USD | -5.03% | -11.39% | -20.92% | +53.16% | 213.57 M USD | ||
| 3476 |  KROS Keros Therapeutics, Inc. - common stock | 10.66 USD | -3.96% | -10.34% | -5.83% | -29.40% | 211.36 M USD | ||
| 3482 |  PLX Protalix BioTherapeutics, Inc. Common Stock | 2.61 USD | -2.97% | -6.79% | -3.33% | -10.62% | 210.29 M USD | ||
| 3489 |  MGNX MacroGenics, Inc. - Common Stock | 3.25 USD | -3.56% | -12.63% | -21.12% | +95.78% | 207.03 M USD | ||
| 3491 |  LRMR Larimar Therapeutics, Inc. - Common Stock | 1.99 USD | 0.00% | -25.19% | -47.49% | -54.25% | 206.73 M USD | ||
| 3493 |  ALEC Alector, Inc. - Common Stock | 1.84 USD | -3.66% | -11.54% | -0.54% | -39.67% | 205.45 M USD | ||
| 3494 |  MDCX Medicus Pharma Ltd. - Common Stock | 3.25 USD | -5.25% | -22.62% | +1811.76% | +175.42% | 205.34 M USD | ||
| 3511 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 8.12 USD | -0.85% | -5.91% | -24.47% | -66.43% | 198.98 M USD | ||
| 3517 |  AMWL American Well Corporation Class A Common Stock | 11.62 USD | -5.83% | -10.27% | -16.16% | +100.69% | 197.64 M USD | ||
| 3519 |  NAGE Niagen Bioscience, Inc. - Common Stock | 2.49 USD | -3.49% | -6.74% | -16.44% | -50.00% | 197.02 M USD | ||
| 3534 |  RNAC Cartesian Therapeutics, Inc. - Common Stock | 6.27 USD | -4.71% | -10.43% | -20.43% | -31.55% | 189.70 M USD | ||
| 3537 |  EVMN Evommune, Inc. Common Stock | 5.17 USD | -12.82% | -15.11% | -45.00% | -70.15% | 187.63 M USD | ||
| 3538 |  RXST RxSight, Inc. - Common Stock | 4.51 USD | -3.43% | -7.01% | -14.10% | -46.69% | 187.59 M USD | ||
| 3539 |  XGN Exagen Inc. - Common Stock | 7.72 USD | -9.81% | -8.31% | -2.03% | -33.33% | 187.02 M USD | ||
| 3542 |  PDEX Pro-Dex, Inc. - Common Stock | 58.26 USD | -2.93% | -6.48% | -17.11% | +105.07% | 186.63 M USD |
ニュース ヘルスケア株
金曜日の取引時間中に動いたヘルスケア株12銘柄
ウィリアム・ブレア、IDEAYAバイオサイエンシズのカバレッジを開始し、アウトパフォーム評価を付与
レベレーション・バイオサイエンシズ、10月20日付で1対7の株式併合を発表
Gate、NeoSoul（DNA）の契約・レバレッジ・スワップ・コピートレードなど複数サービスを上場
Curis、1,666万6,000株の普通株式とワラントを1株当たり0.51ドルで約850万ドル規模で募集開始
タンゴ・セラピューティクス、ESMO Congress 2026において、MTAPdel/RASmut転移性膵管腺癌（PDAC）および非小細胞肺癌（NSCLC）患者を対象とした、ボピメトスタットとダラキソンラシブまたはゾルドンラシブの併用による第1/2相試験の最新データを発表へ
Fractyl HealthのREMAIN-1試験、6カ月の共同主要評価項目を高い統計学的有意性で達成；GLP-1誘導による減量の80%を維持し、シャム群の67%を上回ることを示す
上昇銘柄ヘルスケア株
 NXGLW NexGel, Inc - Warrant | 0.0099 | +52.31% |
 CTSO Cytosorbents Corporation - Common Stock | 4.11 | +34.31% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 0.61 | +22.00% |
 TCRT Alaunos Therapeutics, Inc. - Common Stock | 2.63 | +20.64% |
 REVBW Revelation Biosciences, Inc. - Warrant | 0.0075 | +17.19% |
 CDT CDT Equity Inc. - Common Stock | 0.24 | +14.29% |
 MRKR Marker Therapeutics, Inc. - Common Stock | 1.04 | +13.04% |
 CVKD Cadrenal Therapeutics, Inc. - Common Stock | 1.09 | +12.37% |
下落銘柄ヘルスケア株
 BEATW Heartbeam, Inc. - Warrant | 0.0031 | -65.56% |
 MDXH MDxHealth SA - American Depositary Shares | 0.21 | -65.00% |
 GUTS Fractyl Health, Inc. - Common Stock | 1.55 | -62.74% |
 REVB Revelation Biosciences, Inc. - Common Stock | 0.48 | -36.84% |
 CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
 MBRX Moleculin Biotech, Inc. - Common Stock | 0.28 | -24.32% |
 JAGX Jaguar Health, Inc. - Common Stock | 3.53 | -23.09% |
 SLXN Silexion Therapeutics Corp - Ordinary Shares | 0.15 | -21.05% |